What is the difference between Leqvio and Repatha?
Leqvio and Repatha are both injectable medicines that are used for the treatment of high cholesterol and their action is to specifically lower low density lipoprotein (LDL) cholesterol levels. Although they are both inhibit a protein called PCSK9 they work by different mechanisms. Repatha is a monoclonal antibody that binds directly to PCSK9 in the liver preventing it from binding to LDL receptors. Leqvio blocks the PCSK9 protein by interfering with the translation of PCSK9 messenger RNA. Both have the same result – and that is freeing up LDL receptors on the surface of liver cells which allows LDL cholesterol to be removed from the blood.
Both are approved to treat high LDL levels caused by a genetic condition called heterozygous familial hypercholesterolemia (HeFH) but Leqvio can only be used in adults whereas Repatha may be given to adults and children aged 10 years and older with the condition.
- Leqvio is also approved for use in people with atherosclerotic cardiovascular disease (ASCVD) – a condition where the arteries narrow due to a build-up of plaque
- Repatha can also be given to people who have had a stroke or heart attack to reduce their risk of having another, and to adults and children over the age of 13 with another genetic condition that causes high LDL levels called homozygous familial hypercholesterolemia.
Both are injected subcutaneously – which means just under the skin but you can learn to inject Repatha yourself so you can self-administer it at home, but Leqvio needs to be administered by a health professional. Repatha is given every 2 to 4 weeks but Leqvio only needs to be given twice a year (every 6 months) after an initial loading dose of 2 injections, 3 months apart.
LDL cholesterol is only one of the major lipids and apolipoproteins that are relevant in cardiovascular disease which means both Leqvio and Repatha are usually given in addition to other cholesterol-lowering medicines that target triglycerides, such as statins. They both also should be administered in conjunction with lifestyle changes including a cholesterol-lowering diet and a weight management plan. Regular exercise is also important as well as avoiding smoking.
Neither Leqvio nor Repatha have any reported drug interactions and are not expected to be affected by inhibitors or inducers of cytochrome p450 enzymes or transporters.
Levqio | Repatha | |
---|---|---|
Generic name | Inclisiran | Evolocumab |
Company | Novartis Pharmaceuticals Corporation | Amgen |
FDA Approval date | Dec 2021 | Aug 2015 |
Generic availability | None | None |
Drug class | PCSK9 inhibitor (subclass: small interfering RNA [siRNA]) | PCSK9 inhibitor (subclass: human monoclonal antibody) |
Dosage form | Subcutaneous injection (administered by a healthcare professional) | Subcutaneous injection (self-administered) |
Use | Reduces LDL cholesterol levels | Reduces LDL cholesterol levels |
Indicated for |
|
|
Dosing schedule and administration | Once every 6 months (2 doses per year)* | Once every 2 to 4 weeks |
Common side effects |
|
|
Warnings and precautions | No contraindications listed | Rarely, serious hypersensitivity reactions may occur; monitor for any signs of a rash or anaphylaxis and discontinue if noted |
Approximate cost | $6,500 per year | $6,228 per year |
*After an initial course of 2 injections, 3 months apart
Related questions
References
- Leqvio (inclisiran) Prescribing Information. FDA Access Data. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214012lbl.pdf
- Leqvio (inclisiran) [Package Insert] Updated April 1, 2022. Novartis Pharmaceuticals Corporation https://www.drugs.com/pro/leqvio.html
- What is Leqvio. Leqvio.com. https://www.leqvio.com/what-is-leqvio
- Repatha (evolocumab). Updated 01/2021. Amgen USA Inc.https://www.drugs.com/pro/repatha.html
Read next
What are PCSK9 Inhibitors and how do they work?
The PCSK9 inhibitors are used for the treatment of high-risk patients with elevated cholesterol, especially when statins aren't adequate. They work by blocking PCSK9, leaving more receptors available to capture your "bad" cholesterol (LDL) for break down and removal from the blood. Continue reading
How long can Repatha be kept unrefrigerated?
Repatha can be left unrefrigerated for up to 30 days at room temperature between 68°F to 77°F (20°C to 25°C) as long as it is kept in its original box and is not kept somewhere that gets hotter than 77°F (25°C), for example, a car glove box. This makes it easier to take your medicine with you when you’re on the go. Do not put Repatha back in the refrigerator once you have taken it out. Continue reading
Can Repatha cause high blood pressure?
Repatha can cause high blood pressure (hypertension) as a side effect. Continue reading
Related medical questions
- How do you inject Repatha?
- Does Repatha cause weight gain or loss?
- How much does Repatha cost?
- Can you drink alcohol and take Repatha?
- How does Repatha work?
- How long should you take Repatha?
- Is Repatha effective without a statin?
- How long do Repatha side effects last?
- How fast does Repatha work?
- Can Leqvio be taken without a statin?
- Does Leqvio cause weight gain?
- How is Leqvio injection administered?
- What is the mechanism of action for Leqvio (inclisiran)?
- Is Leqvio FDA approved as a high cholesterol treatment?
- Who is the actor in the Leqvio commercial?
- Where can I find the Leqvio FDA package insert?
- How does Leqvio work in treating high cholesterol?
Drug information
Related support groups
- Repatha (31 questions, 94 members)
- Leqvio (11 questions, 10 members)
- Inclisiran (9 questions, 5 members)
- Evolocumab (8 questions, 4 members)
- Cardiovascular Risk Reduction (75 questions, 26 members)
- High Cholesterol (99 questions, 268 members)
- Heart Attack (75 questions, 189 members)
- Ischemic Stroke (45 questions, 184 members)
- High Cholesterol - Familial Heterozygous (25 questions, 47 members)
- High Cholesterol - Familial Homozygous (20 questions, 17 members)
- Atherosclerosis (3 questions, 14 members)